Latest News From:
:أخر الأخبار من
A groundbreaking multi-cancer blood test has missed key targets in a major NHS trial, raising questions about its early detection capabilities despite some promising signs for aggressive cancers.
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the disease in the United States. The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and …
The post FDA greenlights first blood test to help diagnose Alzheimer’s disease in the US appeared first on Egypt Independent.
